ADVERTISEMENT
'Buy' Medanta Shares Maintains Motilal Oswal; Target Of Rs 1,590
08 Oct 2025, 11:00 AM IST i


Medanta continues to demonstrate clinical leadership, achieving key milestones.
(Photo Source: Company website).
Over the years, Medanta has developed strong capabilities in managing complex and high-risk cases, reflected in a well-diversified revenue mix. In FY25, the top five specialties, cardiac/oncology/ gastro/ neuro/renal collectively, contributed over 66% of healthcare services revenue.

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
ADVERTISEMENT